Clinuvel Pharmaceuticals Stock Forecast

Sell candidate since Jun 02, 2026 Loss -1.23%

The Clinuvel Pharmaceuticals Ltd. stock price fell by -1.23% on the last day (Wednesday, 3rd Jun 2026) from $6.48 to $6.40. During the last trading day the stock fluctuated 0% from a day low at $6.40 to a day high of $6.40. The price has fallen in 5 of the last 10 days and is down by -3.32% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -5 thousand shares and in total, 515 shares were bought and sold for approximately $3.30 thousand.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -7.27% during the next 3 months and, with a 90% probability hold a price between $5.54 and $6.63 at the end of this 3-month period.

CLVLY Signals & Forecast

There are few to no technical positive signals at the moment. The Clinuvel Pharmaceuticals Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $6.65 and $6.69. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, June 01, 2026, and so far it has fallen -7.91%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Clinuvel Pharmaceuticals Ltd. stock

Clinuvel Pharmaceuticals Ltd. finds support from accumulated volume at $6.35 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 3.44%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CLVLY) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect Clinuvel Pharmaceuticals Ltd. to open at $6.40, and during the day (based on 14 day Average True Range), to move between $6.25 and $6.55, which gives a possible trading interval of +/-$0.308 (+/-4.94%) up or down from last closing price. If Clinuvel Pharmaceuticals Ltd. takes out the full calculated possible swing range there will be an estimated 4.94% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $6.35 (0.78%) than the resistance at $6.48 (1.25%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Clinuvel Pharmaceuticals Ltd. stock A Buy?

Clinuvel Pharmaceuticals Ltd. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.788 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $6.40 ( 0.00000000000001%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk